Is obstructive sleep apnea associated with cortisol levels? A systematic review of the research evidence

Sleep Medicine Reviews

Volumn 16, Issue 3, 2012, Pages 243-249

  Tomfohr, Lianne M ^a   Edwards, Kate M ^b   Dimsdale, Joel E ^a,b  

^a SAN DIEGO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Continuous positive airway pressure; Cortisol; Obstructive sleep apnea; Systematic review

Indexed keywords

HYDROCORTISONE;

APNEA HYPOPNEA INDEX; DATA ANALYSIS; DATA SYNTHESIS; DEPRESSION; HUMAN; HYDROCORTISONE BLOOD LEVEL; OBESITY; POSITIVE END EXPIRATORY PRESSURE; QUALITATIVE ANALYSIS; REVIEW; SALIVA LEVEL; SLEEP APNEA SYNDROME; SMOKING; SYSTEMATIC REVIEW;

ADULT; CONTINUOUS POSITIVE AIRWAY PRESSURE; FEMALE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; SLEEP APNEA, OBSTRUCTIVE;

EID: 84856746869     PISSN: 10870792     EISSN: 15322955     Source Type: Journal    
DOI: 10.1016/j.smrv.2011.05.003     Document Type: Review

References (35)

1. Dempsey J.A., Veasey S.C., Morgan B.J., O'Donnell C.P. Pathophysiology of sleep apnea. Physiol Rev 2010, 90:47-112.
2. Shamsuzzaman A.S.M., Gersh B.J., Somers V.K. Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA 2003, 290:1906-1914.
3. Marin J.M., Carrizo S.J., Vicente E., Agusti A.G.N. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005, 365(9464):1046-1053.
4. Späth-Schwalbe E., Gofferje M., Kern W., Born J., Fehm H.L. Sleep disruption alters nocturnal ACTH and cortisol secretory patterns. Biol Psychiatry 1991, 29:575-584.
5. Buckley T.M., Schatzberg A.F. On the interactions of the hypothalamic-pituitary-adrenal (HPA) axis and sleep: normal HPA axis activity and circadian rhythm, exemplary sleep disorders. J Clin Endocr Metab 2005, 90:3106-3114.
6. Lanfranco F., Motta G., Minetto M., Baldi M., Bablo M., Ghigo E., et al. Neuroendocrine alterations in obese patients with sleep apnea syndrome. Int J Endocrin 2010, 2010:1-11.
7. Nakamura T., Chin K., Shimizu K., Kita H., Mishima M., Nakamura T., et al. Acute effect of nasal continuous positive airway pressure therapy on the systemic immunity of patients with obstructive sleep apnea syndrome. Sleep 2001, 24:545-553.
8. Grunstein R.R., Stewart D.A., Lloyd H., Akinci M., Cheng N., Sullivan C.E. Acute withdrawal of nasal CPAP in obstructive sleep apnea does not cause a rise in stress hormones. Sleep 1996, 19:774-782.
9. Vgontzas A.N., Pejovic S., Zoumakis E., Lin H.M., Bentley C.M., Bixler E.O., et al. Hypothalamic-pituitary-adrenal axis activity in obese men with and without sleep apnea: effects of continuous positive airway pressure therapy. J Clin Endocrinol Metab 2007, 92:4199-4207.
10. Henley D.E., Russell G.M., Douthwaite J.A., Wood S.A., Buchanan F., Gibson R., et al. Hypothalamic-pituitary-adrenal axis activation in obstructive sleep apnea: the effect of continuous positive airway pressure therapy. J Clin Endocrinol Metab 2009, 94:4234-4242.
11. Liberati A., Altman D.G., Tetzlaff J., Mulrow C., Gøtzsche P.C., Ioannidis J., et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 2009, 151:65-94.
12. Recommendations for syndrome definition and measurement techniques in clinical research. The report of an American academy of sleep medicine task force. Sleep 1999, 22:667-689. Sleep-related breathing disorders in adults.
13. Barceló A., Barbé F., De la Pena M., Martinez P., Soriano J.B., Piérola J., et al. Insulin resistance and daytime sleepiness in patients with sleep apnoea. Thorax 2008, 63:946-950.
14. Dadoun F., Darmon P., Achard V., Boullu-Ciocca S., Philip-Joet F., Alessi M.C., et al. Effect of sleep apnea syndrome on the circadian profile of cortisol in obese men. Am J Physiol Endocrinol Metab 2007, 293:E466-E474.
15. Carneiro G., Togeiro S.M., Hayashi L.F., Ribeiro-Filho F.F., Ribeiro A.B., Tufik S., et al. Effect of continuous positive airway pressure therapy on hypothalamic-pituitary-adrenal axis function and 24-h blood pressure profile in obese men with obstructive sleep apnea syndrome. Am J Physiol - Endoc M 2008, 295:E380-E384.
16. Lam J.C.M., Yan C.S.W., Lai A.Y.K., Tam S., Fong D.Y.T., Lam B., et al. Determinants of daytime blood pressure in relation to obstructive sleep apnea in men. Lung 2009, 187:291-298.
17. Lanfranco F., Gianotti L., Pivetti S., Navone F., Rossetto R., Tassone F., et al. Obese patients with obstructive sleep apnoea syndrome show a peculiar alteration of the corticotroph but not of the thyrotroph and lactotroph function. Clin Endocrinol 2004, 60:41-48.
18. Panaree B, Chantana M, Wasana S, Chairat N. Effects of obstructive sleep apnea on serum brain-derived neurotrophic factor protein, cortisol, and lipid levels. Sleep Breath, epub, September 24, 2010.
19. Chin K., Shimizu K., Nakamura T., Narai N., Masuzaki H., Ogawa Y., et al. Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation 1999, 100:706-712.
20. Follenius M., Krieger J., Krauth M.O., Sforza F., Brandenberger G. Obstructive sleep apnea treatment: peripheral and central effects on plasma renin activity and aldosterone. Sleep 1991, 14:211-217.
21. Meston N., Davies R.J.O., Mullins R., Jenkinson C., Wass J.A.H., Stradling J.R. Endocrine effects of nasal continuous positive airway pressure in male patients with obstructive sleep apnoea. J Intern Med 2003, 254:447-454.
22. Schmoller A., Eberhardt F., Jauch-Chara K., Schweiger U., Zabel P., Peters A., et al. Continuous positive airway pressure therapy decreases evening cortisol concentrations in patients with severe obstructive sleep apnea. Metab 2009, 58:848-853.
23. Chin K., Ohi M., Kita H., Noguchi T., Otsuka N., Tsuboi T., et al. Effects of NCPAP therapy on fibrinogen levels in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 1996, 153:1972-1976.
24. Pruessner J.C., Wolf O.T., Hellhammer D.H., Buske-Kirschbaum A., Von Auer K., Jobst S., et al. Free cortisol levels after awakening: a reliable biological marker for the assessment of adrenocortical activity. Life Sci 1997, 61:2539-2549.
25. Van Cauter E., Leproult R., Plat L. Age-related changes in slow wave sleep and REM sleep and relationship with growth hormone and cortisol levels in healthy men. JAMA 2000, 284:861-868.
26. Van Cauter E., Leproult R., Kupfer D.J. Effects of gender and age on the levels and circadian rhythmicity of plasma cortisol. J Clin Endocrinol Metab 1996, 81:2468-2473.
27. Otte C., Hart S., Neylan T.C., Marmar C.R., Yaffe K., Mohr D.C. A meta-analysis of cortisol response to challenge in human aging: importance of gender. Psychoneuroendocrinology 2005, 30:80-91.
28. Travison T.G., O'Donnell A.B., Araujo A.B., Matsumoto A.M., McKinlay J.B. Cortisol levels and measures of body composition in middle-aged and older men. Clin Endocrinol 2007, 67:71-77.
29. Kumari M., Chandola T., Brunner E., Kivimaki M. A nonlinear relationship of generalized and central obesity with diurnal cortisol secretion in the Whitehall II Study. J Clin Endocrinol Metab 2010, 95:4415-4423.
30. Steptoe A., Ussher M. Smoking, cortisol and nicotine. Int J Psychophysiol 2006, 59:228-235.
31. Badrick E., Kirschbaum C., Kumari M. The relationship between smoking status and cortisol secretion. J Clin Endocrinol Metab 2007, 92:819-824.
32. Harris M., Glozier N., Ratnavadivel R., Grunstein R.R. Obstructive sleep apnea and depression. Sleep Med Rev 2009, 13:437-444.
33. Parker K.J., Schatzberg A.F., Lyons D.M. Neuroendocrine aspects of hypercortisolism in major depression. Horm Behav 2003, 43:60-66.
34. Krishnan V., Nestler E.J. The molecular neurobiology of depression. Nature 2008, 455:894-902.
35. Edwards K.M., Tomfohr L.M., Mills P.J., Bosch J.A., Ancoli-Israel S., Loredo J.S., et al. Macrophage migratory inhibitory factor (MIF) may be a key factor in inflammation in obstructive sleep apnea. Sleep 2011, 34:161-163.